RTI Surgical (RTIX) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of RTI Surgical (NASDAQ:RTIX) have received an average broker rating score of 3.00 (Hold) from the two analysts that provide coverage for the stock, Zacks Investment Research reports. Two investment analysts have rated the stock with a hold rating.

Brokerages have set a one year consensus price objective of $5.00 for the company and are anticipating that the company will post $0.02 EPS for the current quarter, according to Zacks. Zacks has also assigned RTI Surgical an industry rank of 110 out of 265 based on the ratings given to related companies.

RTIX has been the topic of several analyst reports. Craig Hallum upgraded shares of RTI Surgical from a “hold” rating to a “buy” rating in a report on Friday, March 2nd. BidaskClub upgraded shares of RTI Surgical from a “sell” rating to a “hold” rating in a report on Tuesday, April 10th. Finally, Zacks Investment Research upgraded shares of RTI Surgical from a “sell” rating to a “hold” rating in a report on Wednesday, May 2nd.

RTIX opened at $4.65 on Friday. The company has a current ratio of 3.81, a quick ratio of 1.53 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $288.59 million, a price-to-earnings ratio of 93.00, a PEG ratio of 3.03 and a beta of 1.58. RTI Surgical has a twelve month low of $3.85 and a twelve month high of $6.00.

RTI Surgical (NASDAQ:RTIX) last posted its earnings results on Thursday, May 3rd. The medical equipment provider reported $0.01 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.01. The company had revenue of $69.89 million for the quarter, compared to analyst estimates of $68.70 million. RTI Surgical had a net margin of 2.57% and a return on equity of 2.49%. research analysts predict that RTI Surgical will post 0.1 earnings per share for the current year.

Several large investors have recently modified their holdings of RTIX. Millennium Management LLC raised its holdings in shares of RTI Surgical by 101.8% during the fourth quarter. Millennium Management LLC now owns 591,647 shares of the medical equipment provider’s stock worth $2,426,000 after acquiring an additional 298,508 shares during the period. Foundry Partners LLC raised its holdings in shares of RTI Surgical by 35.8% during the fourth quarter. Foundry Partners LLC now owns 1,107,745 shares of the medical equipment provider’s stock worth $4,542,000 after acquiring an additional 292,320 shares during the period. Municipal Employees Retirement System of Michigan acquired a new stake in shares of RTI Surgical during the first quarter worth $892,000. Allianz Asset Management GmbH raised its holdings in shares of RTI Surgical by 69.0% during the fourth quarter. Allianz Asset Management GmbH now owns 398,085 shares of the medical equipment provider’s stock worth $1,632,000 after acquiring an additional 162,525 shares during the period. Finally, Dimensional Fund Advisors LP raised its holdings in shares of RTI Surgical by 3.8% during the first quarter. Dimensional Fund Advisors LP now owns 4,427,446 shares of the medical equipment provider’s stock worth $20,366,000 after acquiring an additional 160,134 shares during the period. Institutional investors and hedge funds own 67.98% of the company’s stock.

About RTI Surgical

RTI Surgical, Inc, together with its subsidiaries, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes.

Get a free copy of the Zacks research report on RTI Surgical (RTIX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply